In some ways, the flood of vein treatment patent infringement lawsuits is coming to a close. After all, Diomed has resolved its major cases with AngioDynamics and others who infringed on their technology patents before the company went bankrupt. However, there's another major player in vein treatment who is following up on perceived infringements in the industry.
That player is VNUS, a company that has gained a significant amount of attention in the last six months because of the efficiency of its Closure Fast product. The company filed patent infringement lawsuits at the beginning of this year which have been pending.
The issue is now moving forward with an interesting twist since the U.S. Patent Office has approved a new patent related to one of those patents which is part of the pending lawsuit. This means that VNUS now potentially has more right to control the equipment in the vein treatment market. It will be interesting to watch how this plays out and who ends up on top when all of these lawsuits are said and done.
Question of the Day: How do you think this new patent will impact the ongoing story of vein treatment litigation in the United States?
